Skip to main content
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NIULIVA 250 IU/ml SOLUTION FOR INFUSION

Contents of the leaflet

  1. Introduction
  2. What is Niuliva and what is it used for
  3. Before using Niuliva
  4. How to use Niuliva
  5. Possible side effects
  6. Storage of Niuliva
  7. Further information

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Niuliva 250U.I./ml solution for infusion

Human hepatitis B immunoglobulin

Read all of this leaflet carefully before you start using this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you, do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What is Niuliva and what is it used for
  2. Before you use Niuliva
    1. How to use Niuliva
    2. Possible side effects
    3. Storage of Niuliva
  1. Further information

1. What is Niuliva and what is it used for

Niuliva is presented as a solution for intravenous infusion containing 250 U.I./ml of human hepatitis B immunoglobulin.

This medicinal product belongs to the pharmacotherapeutic group called immune sera and immunoglobulins.

Niuliva is used for:

Prevention of hepatitis B virus (HBV) reinfection after liver transplantation due to liver failure caused by hepatitis B in patients without active viral replication before transplantation.

Hepatitis B immunoprophylaxis

  • In case of accidental exposure in non-immunized subjects (including individuals with incomplete or unknown vaccination).
  • In patients undergoing hemodialysis, until vaccination becomes effective.
  • In newborns of mothers carrying the hepatitis B virus.
  • In subjects who did not develop an immune response (unmeasurable anti-hepatitis B antibodies) after vaccination and require continuous prevention due to ongoing risk of hepatitis B infection.

If you have any doubts about the use of Niuliva, consult your doctor.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before using Niuliva

Do not use Niuliva

  • if you are allergic (hypersensitive) to human immunoglobulins or to any of the other components of Niuliva.
  • if you have intolerance to fructose, a rare genetic disease characterized by the inability to break down fructose.

(See special warnings about excipients at the end of this section).

Take special care with Niuliva

Some adverse reactions may occur more frequently

? in the case of high infusion rate.

? if you have hypo- or agammaglobulinemia (a condition characterized by low levels of immunoglobulin in your blood) with or without IgA deficiency.

Pulmonary adverse reactions (acute transfusion-related lung injury, TRALI) may occur if you receive intravenous immunoglobulin.

True hypersensitivity reactions are rare. The symptoms of hypersensitivity reactions are: skin rash, generalized urticaria, chest tightness, difficulty breathing, decreased blood pressure (hypotension), and severe allergic reaction (anaphylaxis).

Niuliva contains a small amount of IgA. If you have IgA deficiency, you are at risk of developing anti-IgA antibodies and suffering allergic reactions after administration of blood-derived products (hemoderivatives) containing IgA. Your doctor should weigh the benefits of treatment with Niuliva against the potential risks of hypersensitivity reactions.

Rarely, human hepatitis B immunoglobulin may induce a drop in blood pressure with an allergic reaction, even if you have previously tolerated treatment with immunoglobulin.

Patients with pre-existing risk factors

Please inform your doctor if you have any other medical condition or disease, as this may require greater caution. In particular, inform your doctor if you have thrombotic risk factors (risk of developing blood clots or thrombi in your circulation).

Consult your doctor, even if any of the above circumstances have occurred to you in the past.

Special safety precautions

When administering medicines derived from human plasma or blood, certain measures must be taken to prevent infections from being transmitted to patients. These measures include careful selection of donors to exclude those at risk of carrying infectious diseases, analysis of specific infection markers in individual donations and plasma pools, as well as inclusion of stages in the manufacturing process to eliminate/inactivate viruses. Despite this, when administering medicines derived from human blood or plasma, the possibility of transmitting infectious agents cannot be entirely excluded. This also applies to emerging or unknown viruses or other types of infections.

The measures taken are considered effective for enveloped viruses such as human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus, and for the non-enveloped hepatitis A virus. The measures taken may have limited value for non-enveloped viruses such as parvovirus B19.

Immunoglobulins have not been associated with hepatitis A or parvovirus B19 infections, possibly because the antibodies against these infections contained in the product are protective.

It is highly recommended that each time you receive a dose of Niuliva, the name of the medicine and batch number administered be recorded to maintain a record of the batches used.

Use of other medicines

? Inform your doctor or pharmacist if you are using or have recently used other medicines, including those obtained without a prescription.

? Effects on vaccines: Niuliva may reduce the effectiveness of certain types of vaccines such as measles, rubella, mumps, and varicella.

Effects on blood tests

If a blood test is performed after receiving Niuliva, please inform the analyst or your doctor that you have received this medicine. The level of some antibodies may increase.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medicine.

Inform your doctor if you are pregnant or breastfeeding. Your doctor will decide whether Niuliva can be used during pregnancy and breastfeeding.

Driving and using machines

No effects on the ability to drive vehicles or use machinery have been observed.

Important information about some of the components of Niuliva

This medicine contains 50mg of sorbitol per ml.If your doctor has informed you that you suffer from intolerance to some sugars, contact them before using this medicine.

In newborns and children up tothe weaning period, hereditary fructose intolerancemay not have been diagnosed yet, and administration of Niuliva may trigger severe effects. When treatment with Niuliva is considered appropriate for newborns and children (especiallyup to the weaning period), it should be exercised with great caution before and during administration of Niuliva due to the amount of sorbitol contained in the product. This is especially important when more than one dose is needed to achieve protective antibody titers.

No interference with blood glucose level determination is expected.

3. How to use Niuliva

Follow these instructions unless your doctor has given you different instructions.

Prevention of hepatitis B virus (HBV) reinfection after liver transplantation due to liver failure caused by hepatitis B in patients without active viral replication before transplantation:

In adults:

10,000 U.I. on the day of transplantation, during surgery. Afterward, 2,000 - 10,000 U.I./day for 7 days, and as needed to maintain antibody levels above 100 - 150 U.I./l in HBV DNA-negative patients.

In children:

The dosage should be adjusted based on body surface area, at 10,000 U.I./1.73 m2.

Hepatitis B immunoprophylaxis:

  • Prevention of hepatitis B in case of accidental exposure in non-immunized subjects:

At least 500 U.I., depending on the intensity of exposure, as soon as possible after exposure, and preferably between 24 - 72 hours.

  • Hepatitis B immunoprophylaxis in patients undergoing hemodialysis:

8 - 12 U.I./kg with a maximum of 500 U.I., every 2 months until seroconversion after vaccination.

  • Prevention of hepatitis B in newborns of mothers carrying the hepatitis B virus, at birth or as soon as possible after birth:

30 - 100 U.I./kg. Administration of hepatitis B immunoglobulin should be repeated until seroconversion after vaccination.

In all these situations, vaccination against hepatitis B virus is strongly recommended. The first dose of the vaccine can be administered on the same day as the human hepatitis B immunoglobulin, although at different sites.

In subjects who did not develop an immune response (unmeasurable anti-hepatitis B antibodies) after vaccination and require continuous prevention, administration of 500 U.I. in adults and 8 U.I./kg in children every 2 months may be considered; the minimum protective antibody titer is considered 10 mU.I./ml.

Niuliva should be administered intravenously at an initial infusion rate of up to 0.02 ml/kg/min for the first 10 minutes. If you tolerate this infusion rate well, your doctor may gradually increase the infusion rate up to a maximum of 0.04 ml/kg/min. Therefore, generally, administration of 5,000 U.I. will take less than 15 minutes.

If no adverse reactions occur, the initial infusion rate for subsequent infusions will also be up to 0.02 ml/kg/min, and if you tolerate this infusion rate well, your doctor may gradually increase the infusion rate up to a maximum of 0.1 ml/kg/min. In general, the administration time for 5,000 U.I. will be less than 10 minutes.

Niuliva should not be mixed with other medicines or intravenous solutions and should be administered using equipment exclusively for its administration.

If you use more Niuliva than you should

If you have been given more Niuliva than you should, consult your doctor or pharmacist immediately.

The consequences of an overdose are not known.

If you forget to use Niuliva

Consult your doctor or pharmacist immediately and follow their instructions.

You should not be given a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Niuliva can cause side effects, although not everybody gets them.

Tell your doctor if you suffer from any of the following side effects during or after infusion:

? Chills

? Headache

? Fever

? Nausea

? Vomiting

? Allergic reaction

? Joint pain

? Decreased blood pressure (hypotension)

? Mild back pain

Rare side effects:

? Sudden drop in blood pressure and, in isolated cases, anaphylactic shock, even if you have not suffered allergic reactions (hypersensitivity) in previous administrations.

? Cases of temporary inflammation of the meninges (reversible aseptic meningitis).

? Cases of temporary reduction in the number of certain blood cells (hemolytic anemia/reversible hemolysis).

? Cases of transient skin reactions.

? Increases in serum creatinine levels and/or acute renal failure.

Very rare side effects:

? Formation of blood clots in the veins (thromboembolic reactions) that can result in sudden lack of blood supply to the heart muscle (myocardial infarction), stroke, pulmonary defects (pulmonary embolism), or severe obstruction of the veins (deep vein thrombosis).

In two clinical studies conducted with Niuliva, the following side effects were observed:

Uncommon (may affect up to 1 in 100 people):

  • Decrease in white blood cells
  • Transplant rejection
  • Hypokinesia
  • Hypotension, hypertension
  • Dry mouth
  • Joint pain
  • Renal failure, acute kidney injury
  • Increased liver enzymes, positive throat culture

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Niuliva

Keep out of the reach and sight of children.

Do not use Niuliva after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.

Store in a refrigerator (between 2°C and 8°C). Do not freeze.

It should be brought to room temperature or body temperature before use.

The solution should be clear or slightly opalescent. Do not use Niuliva if you notice that the solution is cloudy or contains sediment.

Disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Further information

Composition of Niuliva

The active substance is:

Human hepatitis B immunoglobulin. One milliliter of Niuliva contains 50 mg of protein, of which at least 97% is IgG.

The content of human hepatitis B immunoglobulin is 250 U.I./ml (600 U.I./2.4 ml, 1,000 U.I./4 ml, 5,000 U.I./20 ml, and 10,000 U.I./40 ml).

The percentage of IgG subclasses, determined by immunonephelometry, is approximately 74.3% IgG1, 22.1% IgG2, 1.99% IgG3, and 1.61% IgG4.

It contains traces of IgA (less than 0.05 mg/ml).

The other components are sorbitol and water for injectable preparations.

(See section 2, "Before using Niuliva," for more information on components).

Appearance of the product and packaging contents

Niuliva is a solution for infusion. The solution is clear or slightly opalescent, colorless or pale yellow.

Presentation:

Niuliva

Syringes of 600 U.I./2.4 ml and 1,000 U.I./4 ml.

Vials of 5,000 U.I./20 ml and 10,000 U.I./40 ml.

Package size: 1 syringe or 1 vial.

Marketing authorization holder and manufacturer

Instituto Grifols, S.A.

Can Guasch, 2 - Parets del Vallès

08150 Barcelona - SPAIN

Date of last revision of this leaflet:January 2018.

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for NIULIVA 250 IU/ml SOLUTION FOR INFUSION

Discuss questions about NIULIVA 250 IU/ml SOLUTION FOR INFUSION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

NIULIVA 250 IU/ml SOLUTION FOR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in NIULIVA 250 IU/ml SOLUTION FOR INFUSION is hepatitis B immunoglobulin. This information helps identify medicines with the same composition but different brand names.

NIULIVA 250 IU/ml SOLUTION FOR INFUSION is manufactured by Instituto Grifols S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Pulmonologists, Infectious disease physicians, General medicine doctors, Immunologists, Lactation medicine doctors, Intensive care physicians may assess whether NIULIVA 250 IU/ml SOLUTION FOR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, NIULIVA 250 IU/ml SOLUTION FOR INFUSION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (hepatitis B immunoglobulin) include HEPATECT 50 IU/ml SOLUTION FOR INFUSION, IGANTIBE 200 IU/mL Injectable Solution in Pre-filled Syringe, IGANTIBE 200 IU/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media